Impact of pancreatic enzyme replacement therapy on short- and long-term outcomes in advanced pancreatic cancer: meta-analysis of randomized controlled trials
Ammar K, Leeds JS, Ratnayake CB
Published in Expert Review of Gastroenterology & Hepatology
Methodology
Meta-analysis of randomised controlled trials of PERT in advanced pancreatic cancer
Key Findings
PERT was associated with improved nutritional parameters; survival benefit was inconsistent across trials
Conclusions
Enzyme replacement supports nutritional status in pancreatic exocrine insufficiency from malignancy
Limitations
Few trials, heterogeneous dosing and endpoints
Supplements Studied
Impact of pancreatic enzyme replacement therapy on short- and long-term outcomes in advanced pancreatic cancer: meta-analysis of randomized controlled trials.
Outcomes Measured
Impact of pancreatic enzyme replacement therapy on short- and long-term outcomes in advanced pancreatic cancer: meta-analysis of randomized controlled trials.
Related Health Concerns
Study Details
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.